Seasonal control of warfarin therapy [4]

American Journal of Medicine

Volumn 111, Issue 4, 2001, Pages 332-

  Gage, Brian F ^a   Fihn, Stephan D ^b   White, Richard H ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

CLINICAL TRIAL; DRUG EFFICACY; DRUG PACKAGING; DRUG SAFETY; DRUG STORAGE; HUMAN; LETTER; PRIORITY JOURNAL; TABLET FORMULATION; TEMPERATURE DEPENDENCE;

EID: 0034827476     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00889-0     Document Type: Letter

References (6)

1. Two sides of the warfarin issue: Diligence versus potency
2. Management and dosing of warfarin therapy
3. Canadian Atrial Fibrillation Anticoagulation (CAFA) study
4. Adjusted-dose warfarin versus low-intensity fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III randomised clinical trial
5. Monitoring warfarin therapy in patients with lupus anticoagulants